Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Renal phosphate wasting"'
Publikováno v:
AACE Clinical Case Reports, Vol 7, Iss 6, Pp 363-366 (2021)
Objective: Tumor-induced osteomalacia (TIO) is a rare osteomalacia characterized by paraneoplastic secretion of fibroblast growth factor 23. Concomitant occurrence of TIO during pregnancy is rarer still. Our objective was to report a young patient wi
Externí odkaz:
https://doaj.org/article/87d9dc5c5a2243c09801ceec0e352b15
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-5 (2021)
Introduction: Oncogenic osteomalacia (Onc-Ost) is a paraneoplastic phenomenon characterized by hypophosphatemia due to elevated fibroblast growth factor-23 (FGF-23). Onc-Ost has been previously reported in patients with germ line mesenchymal tumors a
Externí odkaz:
https://doaj.org/article/f22c701bea29437cb4c6fa395aa116d3
Autor:
Hiroki Maruyama, Atsumi Taguchi, Mariko Mikame, Hongmei Lu, Norihiro Tada, Muneaki Ishijima, Haruka Kaneko, Mariko Kawai, Sawako Goto, Akihiko Saito, Riuko Ohashi, Yuji Nishikawa, Satoshi Ishii
Publikováno v:
FASEB BioAdvances, Vol 2, Iss 6, Pp 365-381 (2020)
Abstract Low bone mineral density (BMD)—diagnosed as osteoporosis or osteopenia—has been reported as a new characteristic feature of Fabry disease; however, the mechanism underlying the development of low BMD is unknown. We previously revealed th
Externí odkaz:
https://doaj.org/article/fcee537cb437432cbb0f55503ce4611a
Autor:
Kevin Kim-Jun Teh, Matthew Bingfeng Chuah, Shu-Wen Tay, Amanda Yuan-Ling Lim, Joan Joo-Ching Koo
Publikováno v:
European Journal of Case Reports in Internal Medicine (2020)
Parental iron replacement is given to patients with severe iron deficiency or intolerance to oral iron. Hypophosphataemia has been reported to occur as a complication of parental iron replacement, and is postulated to be related to the carbohydrate m
Externí odkaz:
https://doaj.org/article/4cfa91b1eb8b4a75a3279c00833aab95
Autor:
Sunil Kumar Mishra, Mohammad Shafi Kuchay, Ishita Barat Sen, Arpit Garg, Sanjay Saran Baijal, Ambrish Mithal
Publikováno v:
JBMR Plus, Vol 3, Iss 7, Pp n/a-n/a (2019)
ABSTRACT Tumor‐induced osteomalacia (TIO) is a curable condition when the tumor is correctly located and completely removed. These tumors are, however, small and located in regions that make surgical removal difficult and sometimes risky in some pa
Externí odkaz:
https://doaj.org/article/0877f40fdb374371910e46afbb3a54eb
Autor:
Patricia Okamba, Caroline Silve, Benjamin Collet-Fenêtrier, Zead Tubail, Benjamin Savenkoff, Sébastien Daude, Thomas Quinaux
Publikováno v:
Néphrologie & Thérapeutique. 17:466-472
We describe here the case report of a young man of 34-years old suffering from a haemorrhagic rectocolitis and presenting with marked hypophosphatemia secondary to an infusion of ferric-carboxymaltose. The renal phosphate wasting was asserted by a ve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38fcfc7bcfd4448c05892cd769133d35
https://doi.org/10.1016/j.nephro.2020.05.003
https://doi.org/10.1016/j.nephro.2020.05.003
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-5 (2021)
Introduction: Oncogenic osteomalacia (Onc-Ost) is a paraneoplastic phenomenon characterized by hypophosphatemia due to elevated fibroblast growth factor-23 (FGF-23). Onc-Ost has been previously reported in patients with germ line mesenchymal tumors a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f0d8d34b47755049abab015fc50a666
https://doi.org/10.1159/000516390
https://doi.org/10.1159/000516390
Publikováno v:
Hormone Research in Paediatrics. 94:374-389
Introduction: Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) is a rare condition of renal phosphate wasting due to SLC34A3 mutations [Am J Hum Genet. 2006;78(2):193–201]. Patients exhibit low serum phosphorus, high 1,25-dihydroxyvit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a540eec1fda3ff8e51ec154293b2d4b
https://doi.org/10.1159/000520299
https://doi.org/10.1159/000520299
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mariko Mikame, Riuko Ohashi, Yuji Nishikawa, Haruka Kaneko, Muneaki Ishijima, Sawako Goto, Norihiro Tada, Atsumi Taguchi, Hiroki Maruyama, Mariko Kawai, Satoshi Ishii, Akihiko Saito, Hongmei Lu
Publikováno v:
FASEB BioAdvances, Vol 2, Iss 6, Pp 365-381 (2020)
FASEB BioAdvances
FASEB BioAdvances
Low bone mineral density (BMD)—diagnosed as osteoporosis or osteopenia—has been reported as a new characteristic feature of Fabry disease; however, the mechanism underlying the development of low BMD is unknown. We previously revealed that a mous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b8f47a06c05404be94d70394123c2fe
https://doi.org/10.1096/fba.2019-00080
https://doi.org/10.1096/fba.2019-00080